Inventor
BENZ JOERG
DE18 patents
⚠️ This page may combine multiple inventors who share the name “BENZ JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
15 patentsUS11420961B2Aug 23, 2022
Heterocyclic compounds
HOFFMANN LA ROCHE6 citations74
US11981661B2May 14, 2024
Heterocyclic compounds
HOFFMANN LA ROCHE2 citations72
US11814375B2Nov 14, 2023
Heterocyclic compounds
HOFFMANN LA ROCHE2 citations72
US11192957B2Dec 7, 2021
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE2 citations72
US10517945B2Dec 31, 2019
Covalently linked antigen-antibody conjugates
HOFFMANN LA ROCHE3 citations72
US10465000B2Nov 5, 2019
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US9562091B2Feb 7, 2017
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations72
US11802133B2Oct 31, 2023
Heterocyclic compounds as monoacylglycerol lipase inhibitors
HOFFMANN LA ROCHE2 citations71
US11608347B2Mar 21, 2023
Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
HOFFMANN LA ROCHE4 citations71
US11390610B2Jul 19, 2022
Piperazine derivatives as MAGL inhibitors
HOFFMANN LA ROCHE6 citations71
US12098213B2Sep 24, 2024
Antibodies binding to HLA-A2/WT1
HOFFMANN LA ROCHE0 citations61
US12023378B2Jul 2, 2024
Covalently linked antigen-antibody conjugates
HOFFMANN LA ROCHE0 citations61
US12281124B2Apr 22, 2025
Heterocyclic compounds as monoacylglycerol lipase inhibitors
HOFFMANN LA ROCHE0 citations60
US11866490B2Jan 9, 2024
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US11130804B2Sep 28, 2021
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60